Addressing gender-based violence through PEPFAR programs

Daniela Ligiero of the State Department, Sasha Mital of the CDC, and Diana Prieto of USAID, who are co-chairs of the PEPFAR Gender Technical Working Group, write about the "intersection between gender-based violence (GBV) and its impact on HIV risk and access to HIV prevention and treatment for most-at-risk populations (MARPs)" in this post on the State Department's "DipNote" blog. They conclude, "While more programs, policies and science are still needed to address GBV in MARPs, momentum is building to fill existing gaps. By capitalizing on PEPFAR's existing platforms, proven interventions for HIV prevention among MARPs, and the range of partners supporting this work, we can continue to make progress that will bring us closer to the goal of an AIDS-free generation" (12/8).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New two-dose HIV vaccine strategy shows promise for stronger immune response